What to know
Documents developed to inform users of NIOSH Approved® respirators (formerly called user notices) about changes in a test procedure or the NIOSH conformity assessment process.
Conformity Assessment Notices
- CA 2023-1054 – DEVCOM Chemical Biological Center (CBC) Fees for Chemical Warfare Agent (CWA) Testing, effective March 2023. This notice supersedes NIOSH Conformity Assessment Notice NIOSH CA 2019-1023 and the NIOSH Letter to All Manufacturers dated August 22, 2014
- CA 2021-1034R1 – Summarized Information about NIOSH Respirator Approval Program (i) Basic Application Procedures (ii) Quality Assurance Requirements and (iii) Supplier or Subcontractor Agreements. Supersedes: March 2021 version
- CA 2019-1016 – Summary of the Federal Register comments concerning the Department of Transportation Special Permit 16320
- CA 2019-1012 – NIOSH Respirator Approval Contents and Meaning, Supersedes: March 17, 2006 Respirator User Notice – Meaning of NIOSH Approvals May 15, 2015 Letter to All Respirator Manufacturers – NIOSH Respirator Certificate of Approval, Approval Labels and User Instructions
- CA 2018-1003 – NIOSH Use of a Personal Computer (PC) Based System, Microsoft Windows and National Instruments' LabVIEW™ Data Acquisition Software to replace use of the Gould RS3200 Strip Chart Recorder beginning June 15, 2018
- CA 2018-1002 – Intra-Laboratory Comparison of LabVIEW™ Data Acquisition Software to replace use of the Gould RS3200 Strip Chart Recorder
Content Source:
National Institute for Occupational Safety and Health
- NIOSH Approved is a registered certification trademark of the U.S. Department of Health and Human Services (HHS) in the United States and several other countries.